Luohe Chief Pharmaceutical
China Updated 9 July 2026
Luohe Chief Pharmaceutical is a contract manufacturer based in China. It holds 5 active US drug master files and 2 valid CEPs across a filed portfolio of 3 molecules.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Luohe City, China | Not on file |
| China, China | 3017902134 |
What they file, and where
| Molecule | Regulators | Docs |
| Rifamycin | EDQM, US FDA | 4 |
| Rifaximin | EDQM, US FDA | 2 |
| Rifabutin | US FDA | 1 |
Also appears on these molecule pages
Comparing suppliers?
Choose your molecules and target markets. Luohe Chief Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability